Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.4088 +0.0030 (+0.74%)
Streaming Delayed Price Updated: 12:18 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,315
Open 0.4050
Bid (Size) 0.4054 (100)
Ask (Size) 0.4096 (300)
Prev. Close 0.4058
Today's Range 0.4000 - 0.4095
52wk Range 0.3900 - 4.000
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript ↗
HeartBeam (NASDAQ:BEAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts... 
Via Benzinga
Topics Earnings

Performance

YTD
-83.2%
-83.2%
1 Month
-18.2%
-18.2%
3 Month
-47.3%
-47.3%
6 Month
-67.8%
-67.8%
1 Year
-72.0%
-72.0%

More News

Read More
News headline image
HeartBeam Reports Second Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Sets Aug. 13 Call To Review Q2 Results and Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Patent Expands Cardiac Monitoring Platform With Heart Failure and Structural Heart Disease Capabilities
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
Via Investor Brand Network
Topics Death
News headline image
Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks ↗
Via MarketBeat
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam (BEAT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
HeartBeam Reports First Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
From HeartBeam, Inc.
Via Business Wire

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 0.4088
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 09/15/26 12:18 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 14.01M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.